FDA Inspection 1236061 — Northtec Keystone
The FDA completed an inspection of Northtec Keystone on Mar 15, 2024 in Bristol, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 15, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bristol, PA (United States)